<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=35476375865279447&ev=PageView&noscript=1"/>

Amber Enterprises India Limited

NSE: AMBER · Lot size: 100

Amber Enterprises India Limited Open Interest & PCR Analysis

7,940Updated 21 Apr 2026, 01:26 pm IST
PCR
0.68
Bearish signal
Max Pain
7,500
Spot above by ₹440
Total CE OI
1.10M
Call writers
Total PE OI
753K
Put writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish

Data as of 2026-04-21

Frequently Asked Questions

What is Amber Enterprises India Limited PCR (Put-Call Ratio) today?
Amber Enterprises India Limited's current PCR is 0.68. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. Amber Enterprises India Limited's PCR of 0.68 indicates bearish sentiment.
What is Amber Enterprises India Limited OI buildup type today?
Amber Enterprises India Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for Amber Enterprises India Limited?
Amber Enterprises India Limited has total CE (call) OI of 1101800 contracts and total PE (put) OI of 753400 contracts for the nearest expiry. The PCR is 0.68.
How is open interest analysis useful for Amber Enterprises India Limited trading?
OI analysis for Amber Enterprises India Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for Amber Enterprises India Limited?
Amber Enterprises India Limited's max pain is ₹7,500 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.